Developing a new class of engineered live bacterial therapeutics to treat human diseases
出版年份 2020 全文链接
标题
Developing a new class of engineered live bacterial therapeutics to treat human diseases
作者
关键词
-
出版物
Nature Communications
Volume 11, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-04-08
DOI
10.1038/s41467-020-15508-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A rapid and versatile tool for genomic engineering in Lactococcus lactis
- (2019) Tingting Guo et al. Microbial Cell Factories
- A complex human gut microbiome cultured in an anaerobic intestine-on-a-chip
- (2019) Sasan Jalili-Firoozinezhad et al. Nature Biomedical Engineering
- Scale‐down model qualification of ambr® 250 high‐throughput mini‐bioreactor system for two commercial‐scale mAb processes
- (2019) Matthew Manahan et al. BIOTECHNOLOGY PROGRESS
- Programmable bacteria induce durable tumor regression and systemic antitumor immunity
- (2019) Sreyan Chowdhury et al. NATURE MEDICINE
- Comprehensive optimization of composite cryoprotectant for Saccharomyces boulardii during freeze-drying and evaluation of its storage stability
- (2019) Shu Guowei et al. PREPARATIVE BIOCHEMISTRY & BIOTECHNOLOGY
- Targeted Release of Probiotics from Enteric Microparticulated Formulations
- (2019) Cristina Yus et al. Polymers
- An exclusive metabolic niche enables strain engraftment in the gut microbiota
- (2018) Elizabeth Stanley Shepherd et al. NATURE
- Next-generation biocontainment systems for engineered organisms
- (2018) Jeong Wook Lee et al. Nature Chemical Biology
- The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients
- (2018) Vyara Matson et al. SCIENCE
- Effect of cryopreservation and lyophilization on viability and growth of strict anaerobic human gut microbes
- (2018) Lea Bircher et al. Microbial Biotechnology
- Engineered commensal microbes for diet-mediated colorectal-cancer chemoprevention
- (2018) Chun Loong Ho et al. Nature Biomedical Engineering
- Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria
- (2018) Vincent M Isabella et al. NATURE BIOTECHNOLOGY
- Development of a primary human Small Intestine-on-a-Chip using biopsy-derived organoids
- (2018) Magdalena Kasendra et al. Scientific Reports
- Orthogonal Dietary Niche Enables Reversible Engraftment of a Gut Bacterial Commensal
- (2018) Sean M. Kearney et al. Cell Reports
- Scale-Down Model Development in ambr systems: An Industrial Perspective
- (2018) Viktor Sandner et al. Biotechnology Journal
- Expressing cytotoxic compounds in Escherichia coli Nissle 1917 for tumor-targeting therapy
- (2018) Ruijuan Li et al. RESEARCH IN MICROBIOLOGY
- Engineering Microbial Living Therapeutics: The Synthetic Biology Toolbox
- (2018) Danielle B. Pedrolli et al. TRENDS IN BIOTECHNOLOGY
- Polysaccharide Utilization Loci: Fueling Microbial Communities
- (2017) Julie M. Grondin et al. JOURNAL OF BACTERIOLOGY
- A review on Lactococcus lactis: from food to factory
- (2017) Adelene Ai-Lian Song et al. Microbial Cell Factories
- Engineered bacteria can function in the mammalian gut long-term as live diagnostics of inflammation
- (2017) David T Riglar et al. NATURE BIOTECHNOLOGY
- Spatial organization of a model 15-member human gut microbiota established in gnotobiotic mice
- (2017) Jessica L. Mark Welch et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
- (2017) V. Gopalakrishnan et al. SCIENCE
- Engineered probiotic Escherichia coli can eliminate and prevent Pseudomonas aeruginosa gut infection in animal models
- (2017) In Young Hwang et al. Nature Communications
- Intestinal Anti-inflammatory Effects of Outer Membrane Vesicles from Escherichia coli Nissle 1917 in DSS-Experimental Colitis in Mice
- (2017) María-José Fábrega et al. Frontiers in Microbiology
- Engineered Probiotic for the Inhibition of Salmonella via Tetrathionate-Induced Production of Microcin H47
- (2017) Jacob D. Palmer et al. ACS Infectious Diseases
- Synchronized cycles of bacterial lysis for in vivo delivery
- (2016) M. Omar Din et al. NATURE
- Emerging applications of metabolomics in drug discovery and precision medicine
- (2016) David S. Wishart NATURE REVIEWS DRUG DISCOVERY
- Childhood undernutrition, the gut microbiota, and microbiota-directed therapeutics
- (2016) L. V. Blanton et al. SCIENCE
- Genetically Engineered Escherichia coli Nissle 1917 Synbiotics Reduce Metabolic Effects Induced by Chronic Consumption of Dietary Fructose
- (2016) Chaudhari Archana Somabhai et al. PLoS One
- The gut microbiome in health and in disease
- (2015) Andrew B. Shreiner et al. CURRENT OPINION IN GASTROENTEROLOGY
- Engineered in-situ depot-forming hydrogels for intratumoral drug delivery
- (2015) Amir Fakhari et al. JOURNAL OF CONTROLLED RELEASE
- Animal Farm: Considerations in Animal Gastrointestinal Physiology and Relevance to Drug Delivery in Humans
- (2015) Grace B. Hatton et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Quorum-sensingSalmonellaselectively trigger protein expression within tumors
- (2015) Charles A. Swofford et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bifidobacteria Expressing Tumstatin Protein for Antitumor Therapy in Tumor-Bearing Mice
- (2015) C. Wei et al. TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- The outer mucus layer hosts a distinct intestinal microbial niche
- (2015) Hai Li et al. Nature Communications
- Programming a Human Commensal Bacterium, Bacteroides thetaiotaomicron, to Sense and Respond to Stimuli in the Murine Gut Microbiota
- (2015) Mark Mimee et al. Cell Systems
- Incorporation of therapeutically modified bacteria into gut microbiota inhibits obesity
- (2014) Zhongyi Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- A standardised static in vitro digestion method suitable for food – an international consensus
- (2014) M. Minekus et al. Food & Function
- Probiotic Bacteria Reduce Salmonella Typhimurium Intestinal Colonization by Competing for Iron
- (2013) Elisa Deriu et al. Cell Host & Microbe
- Model-Based Drug Development: A Rational Approach to Efficiently Accelerate Drug Development
- (2013) P A Milligan et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Nutritional Basis for Colonization Resistance by Human Commensal Escherichia coli Strains HS and Nissle 1917 against E. coli O157:H7 in the Mouse Intestine
- (2013) Rosalie Maltby et al. PLoS One
- Measuring Growth and Gene Expression Dynamics of Tumor-Targeted S. Typhimurium Bacteria
- (2013) Tal Danino et al. Jove-Journal of Visualized Experiments
- Escherichia coli Nissle 1917 Targets and Restrains Mouse B16 Melanoma and 4T1 Breast Tumors through Expression of Azurin Protein
- (2012) Yunlei Zhang et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- Construction of an inducible cell-communication system that amplifiesSalmonellagene expression in tumor tissue
- (2012) Yumei Dai et al. BIOTECHNOLOGY AND BIOENGINEERING
- Topical drug delivery systems in dermatology: a review of patient adherence issues
- (2012) Xi Tan et al. Expert Opinion on Drug Delivery
- Deep sequencing-based analysis of the anaerobic stimulon in Neisseria gonorrhoeae
- (2011) Vincent M Isabella et al. BMC GENOMICS
- Formulation approaches in enhancement of patient compliance to oral drug therapy
- (2011) Aliasgar Shahiwala Expert Opinion on Drug Delivery
- The Tumor Lysis Syndrome
- (2011) Scott C. Howard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Production of recombinant proteins in E. coli by the heat inducible expression system based on the phage lambda pL and/or pR promoters
- (2010) Norma A Valdez-Cruz et al. Microbial Cell Factories
- LPS/TLR4 signal transduction pathway
- (2008) Yong-Chen Lu et al. CYTOKINE
- Clinical use of E. coli Nissle 1917 in inflammatory bowel disease
- (2008) Michael Schultz INFLAMMATORY BOWEL DISEASES
- A microbial symbiosis factor prevents intestinal inflammatory disease
- (2008) Sarkis K. Mazmanian et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now